Doctors Note Logo

Published on: 8/18/2026

Understanding Autosomal Dominant Transmission: Can One Gene Variant Cause Symptoms?

Yes, a single gene variant can cause symptoms in autosomal dominant conditions, because only one copy of the altered gene, inherited from either parent, is enough to trigger the disorder. Each child of an affected parent has a 50% chance of inheriting the variant, though how strongly symptoms appear can vary widely due to penetrance and expressivity. Some people carry the variant with mild or no obvious signs, while others develop significant health issues, and certain conditions like Huntington's disease or Marfan syndrome follow this pattern. Genetic testing and family history review help clarify risk, but interpretation depends on many individual factors. There are several important details to consider, so see below to understand more.

If you are noticing symptoms you cannot explain or have concerns about an inherited condition in your family, a free, instant, online symptom check can help you organize what you are experiencing and point you toward the right next steps, including which specialist to see or which questions to raise with your doctor.

Last reviewed for medical accuracy: 08/18/2026

answer background

Explanation

Understanding Autosomal Dominant Transmission: Can One Gene Variant Cause Symptoms?

Hypophosphatasia is a rare bone-mineral disorder caused by changes in the ALPL gene, which provides instructions for making an enzyme called alkaline phosphatase. In some families, a single altered copy of this gene (inherited from one parent) is enough to cause signs and symptoms. This pattern is known as autosomal dominant inheritance.

Below, we’ll explain how autosomal dominant transmission works, why one gene variant can lead to hypophosphatasia symptoms, and what you can do if you suspect you or a family member might be affected.


What Is Autosomal Dominant Inheritance?

Autosomal dominant inheritance means:

  • You have two copies of every gene—one from each parent.
  • A change (variant) in just one copy of a gene is enough to cause the disorder.
  • Each child of an affected parent has a 50% chance of inheriting the altered gene.
  • Both males and females are equally likely to be affected.

Key points:

  • Single-gene effect: You don’t need changes in both copies to develop symptoms.
  • Vertical transmission: It often appears in every generation, with an “affected” parent passing it to kids.
  • Variable severity: Even family members with the same variant can have mild or severe features.

Hypophosphatasia Inheritance from One Parent

Hypophosphatasia (HPP) can follow autosomal dominant or autosomal recessive patterns. When inherited in an autosomal dominant way:

  • One altered ALPL gene copy is enough to reduce alkaline phosphatase activity.
  • Even partial enzyme deficiency can disrupt bone and tooth mineralization.
  • Symptoms can appear at any age—from infancy to adulthood.

Common Features of Dominant Hypophosphatasia

  • Early tooth loss (especially baby teeth that fall out before age 5)
  • Frequent fractures or stress fractures
  • Bone pain, muscle weakness
  • Joint pain or stiffness
  • Fatigue and difficulty with endurance activities

Can One Gene Variant Really Cause Symptoms?

Yes. Here’s why a single variant in ALPL can lead to clinical signs:

  1. Haploinsufficiency

    • When one copy of a gene doesn’t produce enough enzyme, the body’s total enzyme level drops below the threshold needed for healthy bone mineralization.
  2. Dominant Negative Effect

    • Some variants produce a faulty enzyme that not only fails to work but also interferes with the normal enzyme made by the unaffected gene copy.
  3. Tissue-Specific Impact

    • Bone and tooth tissues rely heavily on alkaline phosphatase. Even modest reductions can lead to mineralization problems.
  4. Age and Modifier Genes

    • Other genetic factors or environmental influences (like nutrition and physical activity) can shape how severely symptoms appear.

Variable Expressivity and Incomplete Penetrance

Two important concepts explain why family members with the same ALPL variant can look very different:

  • Variable expressivity
    • Range of symptom severity: one person may have mild tooth issues, another may have frequent fractures.
  • Incomplete penetrance
    • Some people who inherit the variant might never show clear symptoms, even though they carry the altered gene.

This variability can make it challenging to predict who will become seriously affected.


What Are the Risks to Children?

If one parent has an autosomal dominant ALPL variant:

  • Each pregnancy has a 50% chance of passing the variant to the child.
  • There’s no difference in risk between sons and daughters.
  • Severity in the child can be milder, similar, or more severe than in the parent due to variable expressivity.

Genetic Testing and Counseling

If you suspect hypophosphatasia in your family, consider:

  • Molecular genetic testing
    • A blood or saliva test can identify ALPL variants.
  • Family history review
    • Document bone or dental issues across relatives.
  • Genetic counseling
    • A trained counselor can explain risks, testing options, and family planning choices.

Benefits of genetic counseling:

  • Clarifies inheritance patterns
  • Helps interpret test results
  • Guides monitoring and preventive strategies
  • Supports informed decisions about future pregnancies

Monitoring and Management

While there is no cure for hypophosphatasia, early recognition and supportive care can improve quality of life. Management may include:

  • Regular dental exams to preserve teeth
  • Orthopedic monitoring for bone health and fracture prevention
  • Physical therapy to maintain muscle strength and joint mobility
  • Pain management strategies, including safe exercise plans
  • Vitamin D and calcium monitoring under doctor supervision

If you’re experiencing unexplained tooth loss, bone pain, fractures, or other related issues, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.


When to Speak to a Doctor

Although hypophosphatasia symptoms can vary, certain signs warrant prompt medical attention:

  • Severe bone pain or sudden fractures
  • Difficulty breathing or eating (in infants)
  • Persistent muscle weakness affecting daily activities
  • New, unexplained dental problems in young children

Always speak to a doctor about anything that could be life-threatening or serious. A healthcare professional can guide you through appropriate testing, referrals, and management plans.


Key Takeaways

  • Hypophosphatasia can be passed down in an autosomal dominant manner, meaning one altered ALPL gene from one parent can cause symptoms.
  • Even a single variant may lead to enzyme deficiency through haploinsufficiency or a dominant negative effect.
  • Symptoms range from mild (early tooth loss) to severe (frequent fractures, bone pain).
  • Variable expressivity and incomplete penetrance explain why severity differs among family members.
  • Genetic testing and counseling are valuable for diagnosis and family planning.
  • Supportive care—dental, orthopedic, physical therapy—can improve outcomes.
  • Use tools like the Ubie Symptom Checker and consult a doctor for any serious concerns.

Understanding how hypophosphatasia inheritance from one parent works empowers you to make informed decisions about testing, monitoring, and care. Early recognition and a targeted management plan can help you or your loved ones maintain bone and dental health over a lifetime.

(References)

  • * Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C, Brusco A, Bosio M, Massella L, Lavoratti G, Roccatello D, Frascá G, Mazzucco G, Muda AO, Conti M, Fasciolo F, Arrondel C, Heidet L, Renieri A, De Marchi M. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int. 2002 Jun;61(6):1947-56. doi: 10.1046/j.1523-1755.2002.00379.x. PMID: 12028435.

  • * Fauvert D, Brun-Heath I, Lia-Baldini AS, Bellazi L, Taillandier A, Serre JL, de Mazancourt P, Mornet E. Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet. 2009 Jun 6;10:51. doi: 10.1186/1471-2350-10-51. Epub 2009 Jun 6. PMID: 19500388; PMCID: PMC2702372.

  • * Lohmann D. Retinoblastoma. Adv Exp Med Biol. 2010;685:220-7. doi: 10.1007/978-1-4419-6448-9_21. PMID: 20687510.

  • * Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KM, Gregg A, Noggle S, Tessier-Lavigne M. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature. 2016 May 5;533(7601):125-9. doi: 10.1038/nature17664. Epub 2016 Apr 27. PMID: 27120160.

  • * Auer-Grumbach M, Toegel S, Schabhüttl M, Weinmann D, Chiari C, Bennett DLH, Beetz C, Klein D, Andersen PM, Böhme I, Fink-Puches R, Gonzalez M, Harms MB, Motley W, Reilly MM, Renner W, Rudnik-Schöneborn S, Schlotter-Weigel B, Themistocleous AC, Weishaupt JH, Ludolph AC, Wieland T, Tao F, Abreu L, Windhager R, Zitzelsberger M, Strom TM, Walther T, Scherer SS, Züchner S, Martini R, Senderek J. Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies. Am J Hum Genet. 2016 Sep 1;99(3):607-623. doi: 10.1016/j.ajhg.2016.07.008. PMID: 27588448; PMCID: PMC5011077.

  • * Pagnamenta AT, Kaisaki PJ, Bennett F, Burkitt-Wright E, Martin HC, Ferla MP, Taylor JM, Gompertz L, Lahiri N, Tatton-Brown K, Newbury-Ecob R, Henderson A, Joss S, Weber A, Carmichael J, Turnpenny PD, McKee S, Forzano F, Ashraf T, Bradbury K, Shears D, Kini U, de Burca A, DDD Study, Blair E, Taylor JC, Stewart H. Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome. Clin Genet. 2019 Jun;95(6):693-703. doi: 10.1111/cge.13533. Epub 2019 Apr 3. PMID: 30859559; PMCID: PMC6563422.

  • * Boucher S, Tai FWJ, Delmaghani S, Lelli A, Singh-Estivalet A, Dupont T, Niasme-Grare M, Michel V, Wolff N, Bahloul A, Bouyacoub Y, Bouccara D, Fraysse B, Deguine O, Collet L, Thai-Van H, Ionescu E, Kemeny JL, Giraudet F, Lavieille JP, Devèze A, Roudevitch-Pujol AL, Vincent C, Renard C, Franco-Vidal V, Thibult-Apt C, Darrouzet V, Bizaguet E, Coez A, Aschard H, Michalski N, Lefevre GM, Aubois A, Avan P, Bonnet C, Petit C. Ultrarare heterozygous pathogenic variants of genes causing dominant forms of early-onset deafness underlie severe presbycusis. Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31278-31289. doi: 10.1073/pnas.2010782117. Epub 2020 Nov 23. PMID: 33229591; PMCID: PMC7733833.

  • * Cousin MA, Creighton BA, Breau KA, Spillmann RC, Torti E, Dontu S, Tripathi S, Ajit D, Edwards RJ, Afriyie S, Bay JC, Harper KM, Beltran AA, Munoz LJ, Falcon Rodriguez L, Stankewich MC, Person RE, Si Y, Normand EA, Blevins A, May AS, Bier L, Aggarwal V, Mancini GMS, van Slegtenhorst MA, Cremer K, Becker J, Engels H, Aretz S, MacKenzie JJ, Brilstra E, van Gassen KLI, van Jaarsveld RH, Oegema R, Parsons GM, Mark P, Helbig I, McKeown SE, Stratton R, Cogne B, Isidor B, Cacheiro P, Smedley D, Firth HV, Bierhals T, Kloth K, Weiss D, Fairley C, Shieh JT, Kritzer A, Jayakar P, Kurtz-Nelson E, Bernier RA, Wang T, Eichler EE, van de Laar IMBH, McConkie-Rosell A, McDonald MT, Kemppainen J, Lanpher BC, Schultz-Rogers LE, Gunderson LB, Pichurin PN, Yoon G, Zech M, Jech R, Winkelmann J, Undiagnosed Diseases Network, Genomics England Research Consortium, Beltran AS, Zimmermann MT, Temple B, Moy SS, Klee EW, Tan QK, Lorenzo DN. Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome. Nat Genet. 2021 Jul;53(7):1006-1021. doi: 10.1038/s41588-021-00886-z. Epub 2021 Jul 1. PMID: 34211179; PMCID: PMC8273149.

  • * Idiiatullina E, Al-Azab M, Lin M, Hrovat-Schaale K, Liu Z, Li X, Guo C, Chen X, Li Y, Gao S, Cui J, Zhou W, Liu L, Zhang Y, Masters SL. Heterozygous de novo dominant negative mutation of REXO2 results in interferonopathy. Nat Commun. 2024 Aug 6;15(1):6685. doi: 10.1038/s41467-024-50878-w. Epub 2024 Aug 6. PMID: 39107301; PMCID: PMC11303720.

  • * Wouters M, Ehlers L, Van Eynde W, Kars ME, Delafontaine S, Kienapfel V, Dzhus M, Schrijvers R, De Haes P, Struyf S, Bucciol G, Itan Y, Bolze A, Voet A, Hombrouck A, Moens L, Ogunjimi B, Meyts I. Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriers. J Exp Med. 2025 Nov 3;222(11). doi: 10.1084/jem.20250499. Epub 2025 Aug 27. PMID: 40864493; PMCID: PMC12382605.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.